1. Commission Delegated Regulation (EU) No 1363/2013;Barroso,2013
2. Considerations on the EU definition of a nanomaterial: science to support policy making;Bleeker;Regul. Toxicol. Pharmacol.,2013
3. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications;Wicki;J. Control. Release,2015
4. Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date;Bobo;Pharm. Res.,2016
5. An open-label, randomized, parallel, phase III trial evaluating the efficacy and safety of polymeric micelle-formulated paclitaxel compared to conventional cremophor EL-based paclitaxel for recurrent or metastatic HER2-negative breast cancer;Park;Cancer Res. Treat.,2016